Tag: biosimilar vs originator
Biosimilar Switching: What Happens When You Change from Originator Biologic
Switching from an originator biologic to a biosimilar is safe for most patients with stable autoimmune conditions. Learn what really happens during the switch, why some people stop treatment, and how to make the transition work for you.
view morerecent posts
Learn how post-marketing studies track drug safety after approval, using FAERS, Sentinel, and real-world data to catch hidden risks. Understand the systems, challenges, and future of pharmacovigilance.
Published ON: 11 FebEdema in CKD is caused by fluid buildup from failing kidneys. Managing it requires a three-part strategy: the right diuretics, strict salt restriction, and compression therapy. Learn how each works-and how to use them safely.
Published ON: 7 FebMost workplace wellness programs fail because employees don’t understand how they benefit. Learn how to educate staff with clear, personalized messaging that boosts participation, cuts costs, and builds trust.
Published ON: 1 FebPolycystic kidney disease is a genetic disorder causing cysts to grow in the kidneys, leading to kidney failure. Learn how ADPKD and ARPKD work, how to manage symptoms, and what new treatments are on the horizon.
Published ON: 7 FebGeneric drugs cost far less than brand-name drugs not because ingredients are cheaper, but because labor costs are structured differently. Learn how scale, regulation, and global production shape the real cost of your prescriptions.
Published ON: 9 Feb